Charles B. O'Keeffe, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 20,000 shares at $2.50 ($50K) on 2018-12-14, disclosed to the SEC on 2018-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CPRX | BUY | 2019-10-11 | $47K | — | Filing → |
| CPRX | BUY | 2018-06-08 | $3K | — | Filing → |
| CPRX | BUY | 2018-06-07 | $13K | — | Filing → |